Product Specifications: Lithium Ion 3.7V / 750mAh - BP-LI-3-CT129
Battery
Battery Specification: 3.7V / 750mAh Ver:
Please sign above and return on approval.
Kindly contact us as soon as possible if the sample is not approved.
- CONTENTS -
1. SCOPE This specification describes the related technical standard and requirements of the BP-LI-3-CT129 rechargeable Li-ion battery pack. 2. Battery Specifications 3. STANDARD TESTING CONDITIONS (No Load)
CC/CV model, constant voltage 4.2V, constant current 0.2C,
end current 0.01C CC/CV model, constant voltage 4.2V, constant current 0.5C,
CC/CV model, constant voltage 4.2V, constant current 1C,
-20℃ -- +60℃ One month -20℃ -- +55℃
BP-LI-3-CT129 – CONFIDENTIAL www.tailorbattery.com Page 2 of 6
Product Specifications: Lithium Ion 3.7V / 750mAh - BP-LI-3-CT129 4. APPEARANCE
Shall be free noticeable flaws breaks, age,
Discoloration, deformation, uneven, and other
Defects which impair the value of the commodity
5. ELECTRICAL CHARACTERISTICS
The battery is charged with constant current 0.2CmA
and constant voltage 4.2v until the charging current is
less than 0.01CmA. The longest charging time is less
The capacity measured after the battery is discharged
with constant current 0.2C until the voltage reaches
2.75V cut-off in one hour after complete charge.
The capacity measured after 500 cycles of complete
charge and discharge at 0.2C current to 2.75V cut-off.
Internal resistance measured at 1KHz after complete
6. TEMPERATURE CAPABILITY
After complete charge, at 60℃, discharging
After relative charge, all batteries being tested are
High temperature stored in chamber of 150℃ for 10 min. After
taking the batteries out of the chamber, all the
After complete charge. At -20℃, discharging
BP-LI-3-CT129 – CONFIDENTIAL www.tailorbattery.com Page 3 of 6
Product Specifications: Lithium Ion 3.7V / 750mAh - BP-LI-3-CT129
7. DESTRUCTION CAPABILITY
Subject to 1 hour 10-55Hz 3.5mm amplitude
(complete packing) state. Then test discharge and
Drop test battery 1.2m above steel board
drop each for 6 surface,4 ride direction
8. CAUTIONS
To ensure proper use of the battery please read the manual carefully before using it.
Handling
Do not expose to, or dispose of the battery in fire. Do not put the battery in a charger or equipment with wrong terminals connected. Avoid shorting the battery Avoid excessive physical shock or vibration. Do not disassemble or deform the battery. Do not immerse in water. Do not use the battery mixed with other different make, type, or model batteries. Keep out of the reach of children.
Charge and discharge
Battery must be charged in appropriate charger only. Never use a modified or damaged charger. Do not leave battery in charger over 24 hours.
Store the battery in a cool, dry and well-ventilated area.
Disposal
Regulations vary for different countries. Dispose of in accordance with local regulations.
SPECIFICATIONS SUBJECT TO CHANGE WITHOUT NOTICE
BP-LI-3-CT129 – CONFIDENTIAL www.tailorbattery.com Page 4 of 6
Product Specifications: Lithium Ion 3.7V / 750mAh - BP-LI-3-CT129 9. Dimensions 10. Characteristics
10.1 Charge/Discharge Characteristics Charge: CC/CV 4.2V, 0.5CmA,End- current 0.01CmA Discharge: 0.5CmA Cut-off at 2.75V;Temperature: 25℃
BP-LI-3-CT129 – CONFIDENTIAL www.tailorbattery.com Page 5 of 6
Product Specifications: Lithium Ion 3.7V / 750mAh - BP-LI-3-CT129
10.2 Charge/Discharge Cycle Life Charge: CC/CV 4.2V,0.5CmA, End-Current 0.01CmA Discharge: 0.5CmA, Cut-off at 2.75V Temperature: 25℃
Charge: CC/CV4.2V, 0.5CmA, End-Current 0.01CmA Discharge: As item 5.0
BP-LI-3-CT129 – CONFIDENTIAL www.tailorbattery.com Page 6 of 6
Montréal parmi les leaders mondiaux en sciences de la vie : Est-ce possible ? Notes d’allocution André Marcheterre Président Merck Frosst Chambre de commerce de Montréal Le 14 mars 2006 L’allocution prononcée fait foi Madame la présidente, distingués invités, Bon midi et merci de votre présence ici aujourd’hui. Les questions de santé font couler beaucoup d’
Mutaties in Standaard afhandeling cumarine-interacties periode november 2002 – oktober 2013 Oktober 2013 Wijziging in de standaard 1. Bij rifampicine/ rifabutine (pag 19) is de passage ‘Een kortdurende kuur van rifampicine (tot maximaal 4 dagen: geen actie’ verwijderd. Gebleken is dat bij een aantal interacterende geneesmiddelen met rifampicine ook bij gebruik korter dan 4 dagen ee